Evolent Health (EVH) Current Leases (2019 - 2026)

Evolent Health's Current Leases history runs 8 years deep, the most recent figure standing at $8.8 million for Q1 2026.

• On a quarterly basis, Current Leases fell 75.05% year-over-year to $8.8 million in Q1 2026; TTM through Mar 2026 was $8.8 million, a 75.05% decrease from a year earlier, with the FY2025 full-year figure at $15.3 million, down 42.57% from the prior year.
• Current Leases slipped to $8.8 million in Q1 2026 per EVH's latest filing, from $15.3 million in the prior quarter.
• Across five years, Current Leases topped out at $35.2 million in Q1 2025 and bottomed at $4.6 million in Q1 2023.
• The 5-year median for Current Leases is $8.8 million (2026), against an average of $12.6 million.
• Across the five-year window, Current Leases surged 294.72% in 2025 and plunged 75.05% in 2026, its largest moves.
• Year by year, Current Leases stood at $7.1 million in 2022, then soared by 36.73% to $9.7 million in 2023, then surged by 174.36% to $26.7 million in 2024, then tumbled by 42.57% to $15.3 million in 2025, then slumped by 42.78% to $8.8 million in 2026.
• Per Business Quant, the three latest EVH Current Leases figures stand at $8.8 million (Q1 2026), $15.3 million (Q4 2025), and $17.9 million (Q3 2025).